Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 8, 2014, Pages

  Naing, Cho ^a   Whittaker, Maxine A ^b   Nyunt Wai, Victor ^a   Mak, Joon Wah ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ANEMIA; ARTICLE; BRAIN MALARIA; HUMAN; INCIDENCE; MALARIA FALCIPARUM; METHODOLOGY; MORTALITY; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; CHILD; COMPLICATION; DRUG RESISTANCE; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; META ANALYSIS; PRESCHOOL CHILD; RESPIRATORY DISTRESS SYNDROME, ADULT;

ADOLESCENT; ADULT; ANEMIA; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84925486068     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003071     Document Type: Article

References (70)

1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, (2007) Vivax malaria:neglected and not benign. Am J Trop Med Hyg 77(6 Suppl): 79–87.
2. Baird JK, (2013) Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev 26: 36–57.
3. Carlton JM, Sina BJ, Adams JH, (2011) Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis 5: e1160.
4. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, et al. (2005) Plasmodium vivax malaria. Emerg Infect Dis 11: 132–134.
5. Guerra CA, Howes RE, Patil AP, Gething PW, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
6. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, et al. (1997) The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 91: 256–262.
7. Lomar AV, Vidal JE, Lomar FP, Barbas CV, Matos GJ, et al. (2005) Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis 9: 425–430.
8. Tjitra E, Anstey NM, Sugiarto P, Wariker N, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Med 5: e128.
9. Price RN, Dorsey G, Nosten F, (2009) Antimalarial therapies in children from Papua New Guinea. N Engl J Med 360: 1254.
10. Nadkar MY, Huchche AM, Singh R, Pazare AR, (2012) Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010–January 2011. J Assoc Physicians India 60: 11–13.
11. Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, et al. (2012) The anaemia of Plasmodium vivax malaria. Malar J 11: 135.
12. Costa FT, Lopes SC, Albrecht L, Ataíde R, Siqueira AM, et al. (2012) On the pathogenesis of Plasmodium vivax malaria: perspectives from the Brazilian field. Int J Parasitol 42: 1099–1105.
13. L'Abbe KA, Detsky AS, O'Rourke K, (1987) Meta-analysis in clinical research. Ann Intern Med 107: 224–233.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P, (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Medicine 6: e1000097.
15. WHO (World Health Organization) (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(Suppl 1): S1–90.
16. Moorthy VS, Reed Z, Smith PG, on behalf of the WHO group on measures of malaria vaccine efficacy (2007) Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. Vaccine 25: 5115–5123.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. Available: www.ohri.ca/programs/clinical_epidemiology/oxford.htm accessed 16 February 2014.
18. Greenland S, Thomas DC, Morgenstern H, (1986) The rare-disease assumption revisited. A critique of estimators of relative risk for case-control studies. Am J Epidemiol 124: 869–983.
19. Higgins JPT, Green S, eds. (2011) Cochrane Handbook for Systematic Reviews of Interventions.Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available; www.cochranehandbook.org. Accessed 18 February 2014
20. Kontopantelis E, Springate DA, Reeves D, (2013) A re-analysis of the cochrane library data: the dangers of unobserved heterogeneity in meta-analyses. PLoS ONE 8(7): e69930 doi:10.1371/journal.pone.0069930
21. Harbord RM, Higgins JPT, (2008) Meta-regression in Stata. The Stata Journal 8: 493–510.
22. PROSPERO International prospective register of systematic reviews (2013) Plasmodium vivax infection on severe malaria in children: a meta-analysis. CRD42013006952
23. Abdallah TM, Abdeen MT, Ahmed IS, Hamdan HZ, Magzoub M, Adam I, (2013) Severe Plasmodium falciparum and Plasmodium vivax malaria among adults at Kassala hospital, eastern Sudan. Malar J 12: 148.
24. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, et al. (2010) Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611–1614.
25. Barber BE, William T, Grigg MJ, Menon J, Auburn S, et al. (2009) A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis 56: 383–397.
26. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, et al, (2007) Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 77: 984–991.
27. Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, et al. (2013) Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study. PLoS Med 10: e1001575.
28. Gehlawat VK, Arya V, Kaushik JS, Gathwala G, (2013) Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India. Pathog Glob Health 107: 210–214.
29. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, et al. (2008) Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127.
30. Haroon H, Fazel PA, Naeem M, Mobin A, Naqvi AH, Makki K, (2013) Hide and seek: hematological aspects of malaria - a developing country perspective. J Infect Dev Ctries 7: 273–279.
31. Jain V, Agrawal A, Singh N, (2013) Malaria in a tertiary health care facility of Central India with special reference to severe vivax: implications for malaria control. Pathog Glob Health 107: 299–304.
32. Kaushik JS, Gomber S, Dewan P, (2012) Clinical and epidemiological profiles of severe malaria in children from Delhi, India. J Health Popul Nutr 30: 113–116.
33. Ketema T, Bacha K, (2013) Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public Health 13: 637.
34. Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, et al. (2010) Clinical features of children hospitalized with malaria–a study from Bikaner, northwest India. Am J Trop Med Hyg 83: 981–989.
35. Kochar DK, Das A, Kochar A, Middha S, Acharya J, et al. (2010) Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: a study from Bikaner (Northwestern India). Platelets 21: 623–627.
36. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, et al. (2012) Risk factors and characterization of Plasmodium vivax associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One 7: e35406.
37. Limaye CS, Londhey VA, Nabar ST, (2012) The study of complications of vivax malaria in comparison with falciparum malaria in Mumbai. J Assoc Physicians India 60: 15–18.
38. Manning L, Laman M, Law I, Bona C, Aipit S, et al. (2011) Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One 6: e29203.
39. Manning L, Laman M, Rosanas-Urgell A, Michon P, Aipit S, et al. (2012) Severe anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study. PLoS Negl Trop Dis 6: e1972.
40. Nurleila S, Syafruddin D, Elyazar IR, Baird JK, (2012) Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba in eastern Indonesia. Am J Trop Med Hyg 87: 41–49.
41. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, et al. (2009) Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis 48: 1704–1712.
42. Rizvi I, Tripathi DK, Chughtai AM, Beg M, Zaman S, et al. (2013) Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in Western Uttar Pradesh, India. Ann Afr Med 12: 155–159.
43. Shaikh S, Memon H, Iohano B, Shaikh A, Ahmed I, et al. (2012) Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in south-eastern Pakistan. Malar J 11: 144.
44. Sharma R, Gohain S, Chandra J, Kumar V, Chopra A, et al. (2012) Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India. Paediatr Int Child Health 32: 152–157.
45. Singh R, Kumar S, Rana SK, Thakur B, Singh SP, (2013) A comparative study of clinical profiles of vivax and falciparum malaria in children at a tertiary care centre in uttarakhand. J Clin Diagn Res 7: 2234–2237.
46. Zubairi AB, Nizami S, Raza A, Mehraj V, Rasheed AF, et al. (2013) Severe Plasmodium vivax malaria in Pakistan. Emerg Infect Dis 19: 1851–1854.
47. Tanwar GS, Khatri PC, Sengar GS, Kochar A, Kochar SK, et al. (2011) Clinical profiles of 13 children with Plasmodium vivax cerebral malaria. Ann Trop Paediatr 31: 351–356.
48. Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, et al. (2012) Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study. PLoS Med 9: e1001305.
49. Raposo CC, Santos JB, Santos GM, Gonçalves Eda G, Silva AR, et al. (2013) Plasmodium vivax malaria: related factors to severity in the State of Maranhao, Brazil. Rev Soc Bras Med Trop 46: 67–72.
50. Sharma S, Aggarwal KC, Deswal S, Raut D, Roy N, et al. (2013) The unusual presentation of a usual organism - the changing spectrum of the clinical manifestations of Plasmodium vivax malaria in children: a retrospective study. J Clin Diagn Res7: 1964–1947.
51. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, et al. (2007) The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76: 997–1008.
52. Khaireh BA, Briolant S, Pascual A, Mokrane M, Machault V, et al. (2012) Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants. Malar J 11: 395.
53. Leal-Santos FA, Silva SB, Crepaldi NP, Nery AF, Martin TO, et al. (2013) Altered platelet indices as potential markers of severe and complicated malaria caused by Plasmodium vivax: a cross-sectional descriptive study. Malar J 12: 462.
54. Kwak YG, Lee HK, Kim M, Um TH, Cho CR, (2013) Clinical characteristics of vivax malaria and analysis of recurred patients. Infect Chemother 45: 69–75.
55. Safeukui-Noubissi I, Ranque S, Poudiougou B, Keita M, Traore A, et al. (2004) Risk factors for severe malaria in Bamako, Mali: a matched case-control study. Microbes Infect 6: 572–578.
56. Lacerda MV, Mourao MP, Alexandre MA, Siqueira AM, Magalhaes BM, et al. (2012) Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J 11: 12.
57. Cullen KA, Arguin PM, Division of parasitic diseases and malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC) (2013) (2013) Malaria surveillance–United States, 2011. MMWR Surveill Summ 62: 1–17.
58. Nicol WD, (1933) The relation of syphilis to mental disorder and the treatment of G.P.I. by malaria. Br J Vener Dis 9: 219–229.
59. Baird JK, (2007) Neglect of Plasmodium vivax malaria. Trends Parasitol 23: 533–539.
60. Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, et al. (2012) Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 55: e67–74.
61. Mueller I, Kaiok J, Reeder JC, Cortes A, (2002) The population structure of Plasmodium falciparum and Plasmodium vivax during an epidemic of malaria in the eastern highlands of Papua New Guinea. Am J Trop Med Hyg 67: 459–464.
62. Collins WE, Jeffery GM, Roberts JM, (2003) A retrospective examination of anemia during infection of humans with Plasmodium vivax. Am J Trop Med Hyg 68: 410–41263.
63. Handayani S, Chiu DT, Tjitra E, Kuo JS, Lampah D, et al. (2009) High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J Infect Dis 199: 445–450.
64. Parakh A, Agarwal N, Aggarwal A, Aneja A, (2009) Plasmodium vivax malaria in children: uncommon manifestations. Ann Trop Paediatr 29: 253–256.
65. Anstey NM, Russell B, Yeo TW, Price RN, (2009) The pathophysiology of vivax malaria. Trends Parasitol 25: 220–227.
66. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, et al. (2007) Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and post-treatment alveolar-capillary inflammation. J Infect Dis 195: 589–596.
67. Cunnington AJ, Riley EM, Walther M, (2013) Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes. Trends Parasitol 29: 585–592.
68. Baird JK, (2004) Minireview: Chloroquine resistance in Plasmodium vivax. Antimicrob Agents chemother 48: 4075–4083.
69. Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, et al. (2008) Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis 198: 1558–1564.
70. Kling PJ, Schmidt RL, Roberts RA, Widness JA, (1996) Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr 128: 791–796.